Medical Communications

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …

According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …

According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting …

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final …

NICE has issued a Final Appraisal Document (FAD) recommending Forxiga (dapagliflozin) within its marketing authorisation for the treatment of adults …

Clinical research organisation, Emmes, announced its role as a Data Coordinating Center on a team whose work has accelerated paediatric …

Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca, and Unicorn Capital Partners, a biotech-specialised VC fund, announced …

BeiGene, focused on developing innovative and affordable medicines, announced that the Center for Drug Evaluation (CDE) of the China National …

The Drugs Controller General of India (DCGI) has given permission to Bharat Biotech to conduct clinical trials for the use …

In a BBC News interview, WHO shared their views against easing pandemic restrictions, as new variants flare up anywhere until …

European Union health ministers will try to find a common line on Friday over a potential fourth dose of COVID-19 …

As the government in England relaxes COVID-19 restrictions, new data from the Francis Crick Institute raise concerns over the impact …

Cambridge researchers have developed an artificial pancreas which may beat standard treatment in controlling Type 1 diabetes in young children. …

Clover Biopharmaceuticals has announced that final efficacy data from SPECTRA, a global Phase II/III clinical trial into its COVID-19 vaccine …